Association Between BRCA1 Expression Status and Breast Cancer Metastasis Index (cM) in West Nusa Tenggara
DOI:
10.29303/jbt.v26i3.11751Published:
2026-07-13Downloads
Abstract
Breast cancer remains a major cause of mortality among Indonesian women, with metastasis as its primary prognostic determinant. Although BRCA1 is a key tumor suppressor involved in genomic stability, its association with the breast cancer metastasis index in Indonesian patients remains limited. This research was designed to evaluate the association between BRCA1 expression and breast cancer metastasis index (cM), as well as differences in BRCA1 expression across metastasis categories. A cross-sectional observational study design was employed using 32 samples selected by purposive sampling, consisting of medical records and paraffin-embedded tissue blocks obtained from Pathology Anatomy Laboratory of the NTB provincial hospital. BRCA1 expression was assessed by immunohistochemistry. Bivariate analysis between variables was performed using the Fisher’s Exact test. Of 32 patients, 78.1% were classified as cM1. No significant association was identified between BRCA1 expression and metastasis index (p = 0.394), although low BRCA1 expression was descriptively more frequent in metastatic cases. BRCA1 expression alone is not an independent determinant of metastasis in breast cancer patients in NTB. This suggests that metastasis is multifactorial. Studies with larger samples and additional biomarkers such as hormonal receptors, proliferation index, and metastasis-related proteins are suggested to investigate the metastatic risk in this population.
Keywords:
BRCA1 expression; Breast cancer; Immunohistochemistry; Metastasis index.References
Cancer Research UK. (2023). TNM staging for breast cancer. https://www.cancerresearchuk.org/about-cancer/breast-cancer/stages-grades/tnm-staging
Chen, R. et al. (2020) ‘Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution’, Modern Pathology, 33(12), pp. 2499–2506. DOI: https://doi.org/10.1038/s41379-020-0615-z
Dahlan, M. S. (2011). Statistik untuk Kedokteran dan Kesehatan (5th ed.). Salemba Medika.
DINKES NTB (2024) Profil Kesehatan Nusa Tenggara Barat Tahun 2023. https://dinkes.ntbprov.go.id/profil-kesehatan/
Dos Santos, B. J., Balabram, D., Gomes, V. M. R., de Castro, C. C. C., Diniz, P. H. C., Buzelin, M. A., & Nunes, C. B. (2024). Changes in Invasive Breast Carcinomas after Neoadjuvant Chemotherapy Can Influence Adjuvant Therapeutic Decisions. Cancer Research and Treatment, 56(1), 178–190. DOI: https://doi.org/10.4143/crt.2023.386
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., Liu, B., Lei, Y., Du, S., Vuppalapati, A., Luu, H. H., Haydon, R. C., He, T. C., & Ren, G. (2018). Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. In Genes and Diseases (Vol. 5, Issue 2, pp. 77–106). Chongqing University. DOI: https://doi.org/10.1016/j.gendis.2018.05.001
Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram I, & Bray F. (2024a). Global Cancer Observatory: Cancer Today. https://gco.iarc.who.int/today
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, & Bray F. (2024b). Global Cancer Observatory: Cancer Today- Indonesia. https://gco.iarc.who.int/today
Fu, X., Tan, W., Song, Q., Pei, H., & Li, J. (2022). BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies. In Frontiers in Cell and Developmental Biology (Vol. 10). Frontiers Media S.A. DOI: https://doi.org/10.3389/fcell.2022.813457
Gerstberger, S., Jiang, Q., & Ganesh, K. (2023). Metastasis. In Cell (Vol. 186, Issue 8, pp. 1564–1579). Elsevier B.V. DOI: https://doi.org/10.1016/j.cell.2023.03.003
Gorodetska, I., Kozeretska, I., & Dubrovska, A. (2019). BRCA genes: The role in genome stability, cancer stemness and therapy resistance. In Journal of Cancer (Vol. 10, Issue 9, pp. 2109–2127). Ivyspring International Publisher. DOI: https://doi.org/10.7150/jca.30410
Hedau, S., Batra, M., Singh, U. R., Bharti, A. C., Ray, A., & Das, B. C. (2015). Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer. Journal of Cancer Research and Therapeutics, 11(1), 158–163. DOI: https://doi.org/10.4103/0973-1482.140985
Hu, M., Shao, B., Ran, R., & Li, H. (2021). Prognostic factors for patients with metastatic breast cancer: A literature review. Translational Cancer Research, 10(4), 1644–1655. DOI: https://doi.org/10.21037/tcr-20-2119
Irianiwati, I., Gurky, T. C., Anwar, S. L., Bawono, R. G., & Dwianingsih, E. K. (2025). Correlation between BRCA1 expression and the advanced stage of triple-negative breast cancer. Molecular and Clinical Oncology, 22(4). DOI: https://doi.org/10.3892/mco.2025.2827
Issac, R. M., Saldanha, P., Mathai, J. M., Mathews, R., Kumari, B., & Chacko, T. (2021). Potential role of BRCA1 protein expression as a prognostic tissue biomarker in breast carcinoma: An immunohistochemical and clinicopathologic study from South India. Oncology in Clinical Practice, 17(5), 205–211. DOI: https://doi.org/10.5603/OCP.2021.0031
Krishnan, R., Patel, P. S., & Hakem, R. (2022). Brca1 and metastasis: Outcome of defective DNA repair. In Cancers (Vol. 14, Issue 1). MDPI. DOI: https://doi.org/10.3390/cancers14010108
Kumar, M., Sahu, R. K., Goyal, A., Sharma, S., Kaur, N., Mehrotra, R., Singh, U. R., & Hedau, S. (2017). BRCA1 promoter methylation and expression - associations with ER+, PR+ and HER2+ subtypes of breast carcinoma. Asian Pacific Journal of Cancer Prevention, 18(12), 3293–3299. DOI: https://doi.org/10.22034/APJCP.2017.18.12.3293
NIH. (2024). BRCA Gene Changes: Cancer Risk and Genetic Testing. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet
Putri, N. A., Cahyawati, T. D., & Wedayani, A. A. N. (2024). Pengabdian masyarakat pelaksaan skrining tumor payudara. Jurnal Pengabdian Magister Pendidikan IPA, 7(2), 561–566. DOI: https://doi.org/10.29303/jpmpi.v7i2.8072
Rakha, E. A., El-Sheikh, S. E., Kandil, M. A., El-Sayed, M. E., Green, A. R., & Ellis, I. O. (2007). Expression of BRCA1 protein in breast cancer and its prognostic significance. Human Pathology, 39(6), 857–865. DOI: https://doi.org/10.1016/j.humpath.2007.10.011
Rizka, R., Novrita Padauleng, Fathul Djannah, Bq. Ratna Kumaladewi, Rashieka Salma Aulia, Rommy Healthy Mikaila, Muhammad Fikri Adidaifa, & Bq. Nurhandini Wulandari. (2024). BRCA1 Expression Profile in Breast Cancer Patients in West Nusa Tenggara. Unram Medical Journal, 13(4), 235–238. DOI: https://doi.org/10.29303/jk.v13i4.5834
Sadeghi, F., Asgari, M., Matloubi, M., Ranjbar, M., Karkhaneh Yousefi, N., Azari, T., & Zaki-Dizaji, M. (2020). Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: Review of radiosensitivity assays. In Biological Procedures Online (Vol. 22, Issue 1). BioMed Central Ltd. DOI: https://doi.org/10.1186/s12575-020-00133-5
Szarszewska, M., Markowska, A., Jach, R., Marszałek, A., Filas, V., Bednarek, W., Olejek, A., Tomczak, P., Sajdak, S., Nowak-Markwitz, E., Jaszczyńska-Nowinka, K., Stanisławiak-Rudowicz, J., Gryboś, A., Chudecka-Głaz, A., Gryboś, M., Adamska, K., Ramlau, R., Markowska, J., & Knapp, P. (2019). Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis – A multicentre study. Advances in Medical Sciences, 64(2), 235–240. DOI: https://doi.org/10.1016/j.advms.2018.12.007
World Health Organization. (2019) Classification of Tumours: Breast tumours. 5th ed., vol. 2. Lyon, France: International Agency for Research on Cancer. https://publications.iarc.fr/581.
Yang, J., Qi, L., Chiang, H.C., Yuan, B., Li, R. & Hu, Y. (2021) ‘BRCA1 Antibodies Matter’, International Journal of Biological Sciences, 17(12), pp. 3239-3254. DOI: 10.7150/ijbs.63115. PMCID: PMC8375228.
License
Copyright (c) 2026 Alia, Rizka Vidya Lestari, Yan Adhitya Kusuma
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
